Ultra V, Selected as Ministry of SMEs and Startups ‘Global Powerhouse 1000+ Project’ 

Ultracol, etc exported to over 60 countries around the world, focusing on expanding into the global market

Biomedical Beauty Group Ultra V (CEO Kwon Han-Jin) recently announced that it was selected as a growth company (export amount of 1 million to 1.5 million dollars) for the 2024 'Global Powerhouse 1000+ Project' hosted by the Ministry of SMEs and Startups.

Kwon Han-Jin CEO

The ‘Global Small and Medium Enterprises 1000+ Project’ is a project that discovers export SMEs with high growth potential and fosters them into leading export companies by supporting them in various fields such as marketing and finance. Companies that are eligible for support are selected through fair and strict evaluations.

A total of 2,080 companies applied for this Global Small and Medium Enterprises 1000+ Project, but only 473 companies were finally selected.

It is known that the companies selected for the ‘Global Small and Medium Enterprises 1000+ Project’ showed a high competition rate of 4.4 to 1 because they are provided with various benefits such as various export support projects, policy financing, guarantees and insurance, interest rates and foreign exchange transaction conditions at commercial banks, preferential treatment for R&D projects and local government support projects.

Ultra V is a global biomedical beauty group that manufactures and exports cosmetics and medical devices, exporting and selling them to over 60 countries around the world through its self-developed absorable thread lifting and Ultracol.

In particular, Ultracol is a product developed by Ultra V’s independent technology that uses PDO (Polydioxanone), a harmless ingredient to the human body, in the form of small microspheres. This technology has been recognized and currently holds KFDA certification, European CE certification, and Hainan Province CFDA certification in China. It has also won the IR52 Jang Yeong-sil Award and the Republic of Korea Patent Award for its unique patented technology.

An Ultra V official said, “We are proud that we were evaluated as a company with high growth potential with outstanding technology and innovation in the fiercely competitive Global Small and Medium Enterprises 1000+ project,” and “We believe that our efforts to diversify our markets have been recognized, as sales have recently increased in the Middle East, Europe, North America, and South America in addition to the Asian market.”

He continued, “We will do our best to enhance Ultra V’s export competitiveness and expand our presence in the global market through this Global Small and Medium Enterprises 1000+ designation.”

Meanwhile, Ultra V completed product certification in Hainan Province, China in December based on its innovative technology and products and is currently conducting a biological safety evaluation for entry into Msainland China and registering ANVISA products for sales in Brazil this year.